Travera

Cambridge, United States

Travera uses a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells.

Jun 2023

Non-equity Assistance

Top Investors

National Science FoundationMedTech Innovator

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Travera's investors?

Travera's investors include National Science Foundation, MedTech Innovator.

Where is Travera headquartered?

Travera is headquartered in Cambridge, United States.

What does Travera do?

Travera uses a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells.

What stage is Travera at?

Travera is at the Non-equity Assistance stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 6, 2023.

MLA

"Travera — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/travera. Accessed July 1, 2026.

APA

VCBacked. (2023). Travera — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/travera

Wikipedia (cite web)

{{cite web |title=Travera — Funding & Investors |url=https://www.vcbacked.co/company/travera |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 6, 2023.